MOH vs. XPEL

Last updated Apr 2, 2026

Compare and contrast key facts about Molina Healthcare, Inc. (MOH) and XPEL, Inc. (XPEL).

Performance

MOH vs. XPEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Molina Healthcare, Inc. (MOH) and XPEL, Inc. (XPEL). The values are adjusted to include any dividend payments, if applicable.

MOH vs. XPEL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MOH Molina Healthcare, Inc.	-21.74%	-40.37%	-19.45%	9.41%	3.82%	49.56%	56.74%	16.75%	51.56%	41.32%
XPEL XPEL, Inc.	-10.42%	24.96%	-25.83%	-10.34%	-12.04%	32.43%	251.95%	140.10%	335.82%	0.00%

Fundamentals

Market Cap MOH : $6.90B XPEL : $1.24B
EPS MOH : $8.92 XPEL : $1.85
PE Ratio MOH : 15.22 XPEL : 24.16
PEG Ratio MOH : 6.16 XPEL : 1.68
PS Ratio MOH : 0.16 XPEL : 2.60
PB Ratio MOH : 1.70 XPEL : 4.34
Total Revenue (TTM) MOH : $45.43B XPEL : $476.20M
Gross Profit (TTM) MOH : $3.37B XPEL : $201.02M
EBITDA (TTM) MOH : $976.00M XPEL : $79.75M

Returns By Period

In the year-to-date period, MOH achieves a -21.74% return, which is significantly lower than XPEL's -10.42% return. Over the past 10 years, MOH has underperformed XPEL with an annualized return of 7.66%, while XPEL has yielded a comparatively higher 49.44% annualized return.

MOH

• 1D: 1.89%
• 1M: -10.89%
• YTD: -21.74%
• 6M: -29.55%
• 1Y: -58.55%
• 3Y*: -20.22%
• 5Y*: -10.42%
• 10Y*: 7.66%

XPEL

• 1D: 1.02%
• 1M: 4.03%
• YTD: -10.42%
• 6M: 34.47%
• 1Y: 53.75%
• 3Y*: -13.02%
• 5Y*: -3.97%
• 10Y*: 49.44%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MOH vs. XPEL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MOH

MOH Risk / Return Rank: 8
MOH Sharpe Ratio Rank: 4
MOH Sortino Ratio Rank: 6
MOH Omega Ratio Rank: 4
MOH Calmar Ratio Rank: 7
MOH Martin Ratio Rank: 15

XPEL

XPEL Risk / Return Rank: 74
XPEL Sharpe Ratio Rank: 78
XPEL Sortino Ratio Rank: 77
XPEL Omega Ratio Rank: 71
XPEL Calmar Ratio Rank: 72
XPEL Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MOH vs. XPEL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and XPEL, Inc. (XPEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MOH	XPEL	Difference
Sharpe ratio Return per unit of total volatility	-1.00	1.17	-2.18
Sortino ratio Return per unit of downside risk	-1.36	1.99	-3.35
Omega ratio Gain probability vs. loss probability	0.79	1.23	-0.45
Calmar ratio Return relative to maximum drawdown	-0.90	1.64	-2.54
Martin ratio Return relative to average drawdown	-1.28	4.47	-5.75
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MOH vs. XPEL - Sharpe Ratio Comparison

The current MOH Sharpe Ratio is -1.00, which is lower than the XPEL Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of MOH and XPEL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	MOH	XPEL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.00	1.17	-2.18
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.27	-0.07	-0.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.19	0.78	-0.59
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	0.08	+0.17

Correlation

The correlation between MOH and XPEL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MOH vs. XPEL - Dividend Comparison

Neither MOH nor XPEL has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

MOH vs. XPEL - Drawdown Comparison

The maximum MOH drawdown since its inception was -70.76%, smaller than the maximum XPEL drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for MOH and XPEL.

Drawdown Indicators

	MOH	XPEL	Difference
Max Drawdown Largest peak-to-trough decline	-70.76%	-99.77%	+29.01%
Max Drawdown (1Y) Largest decline over 1 year	-65.28%	-31.79%	-33.49%
Max Drawdown (5Y) Largest decline over 5 years	-70.76%	-75.62%	+4.86%
Max Drawdown (10Y) Largest decline over 10 years	-70.76%	-75.62%	+4.86%
Current Drawdown Current decline from peak	-67.63%	-55.91%	-11.72%
Average Drawdown Average peak-to-trough decline	-24.31%	-52.38%	+28.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	46.09%	11.66%	+34.43%

Volatility

MOH vs. XPEL - Volatility Comparison

The current volatility for Molina Healthcare, Inc. (MOH) is 12.21%, while XPEL, Inc. (XPEL) has a volatility of 14.11%. This indicates that MOH experiences smaller price fluctuations and is considered to be less risky than XPEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MOH	XPEL	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.21%	14.11%	-1.90%
Volatility (6M) Calculated over the trailing 6-month period	45.88%	27.26%	+18.62%
Volatility (1Y) Calculated over the trailing 1-year period	58.53%	46.04%	+12.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	38.93%	55.05%	-16.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.85%	63.86%	-23.01%

Financials

MOH vs. XPEL - Profitability Comparison

The chart below illustrates the profitability comparison between Molina Healthcare, Inc. and XPEL, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

MOH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Molina Healthcare, Inc. reported a gross profit of 0.00 and revenue of 11.38B. Therefore, the gross margin over that period was 0.0%.

XPEL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, XPEL, Inc. reported a gross profit of 51.18M and revenue of 122.27M. Therefore, the gross margin over that period was 41.9%.

MOH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Molina Healthcare, Inc. reported an operating income of -162.00M and revenue of 11.38B, resulting in an operating margin of -1.4%.

XPEL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, XPEL, Inc. reported an operating income of 15.48M and revenue of 122.27M, resulting in an operating margin of 12.7%.

MOH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Molina Healthcare, Inc. reported a net income of -160.00M and revenue of 11.38B, resulting in a net margin of -1.4%.

XPEL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, XPEL, Inc. reported a net income of 13.41M and revenue of 122.27M, resulting in a net margin of 11.0%.